Recent Blog Posts

View Post: Respiratory Research
Full text
The bioavailability and airway ... ...
View Blog: The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial .... ICS/LABA combination therapies (budesonide/formoterol or salmeterol/fluticasone) were switched to equivalent doses of beclomethasone dipropionate (BDP). Use of other corticosteroids (including nasal and oral) was not permitted throughout the study.

---

View Post: Leukotriene modifier drug label change requested by FDA - MPR
16 Jun 2009
ATROVENT INH SOLN. Respiratory Tract > Asthma/COPD. Ipratropium bromide 0.02% (500micrograms in 2.5mL); for oral inhalation; preservative-free. ... Updated: 2/4/2009. QVAR. Respiratory Tract > Asthma/COPD. Beclomethasone dipropionate 40 micrograms/inh, 80 micrograms/inh; metered dose inhaler; CFC-free. ...
View Blog: Latest articles from MPR News - http://www.empr.com/

---

View Post: Asthma/COPD/allergy - Windows Live
2 Dec 2008
Oral systemic corticosteroids: 1) methylprednisolone. 2) prednisolone. 3) prednisone. Inhaled corticosteroids: 1) beclomethasone HFA/Beconase AQ. 2) budesonide DPI & nebulizer/Rhinocort aqua 3) flunisolide MDI/AeroBid. 4) Fluticasone MDI/ Flovent ... 3) for COPD: Albuterol and Ipratropium/Combivent. Mast cell stabilizers. 1) Cromolyn (MDI, Nebulizer). 2) Nedocromil (MDI). Anti-IgE/Immunomodulators: 1) omalizumab. Leukotriene Modifiers (LTRA). 1) Montelukast (oral only) ...
View Blog: Alice in Wonderland - http://yayin7172.spaces.live.com/

---

View Post: RESPIRATORY DRUGS
28 Oct 2009
Slide 20: I. Bronchodilators Methylxanthine drugs  Drug Interactions:  Erythromycin, cimetidine, cirrhosis, CHF, acute pulmonary edema -  half-life Phenytoin, barbiturates, cigarette smoking, rifampicin, oral contraceptives -  clearance ... derivative of atropine Tiotro pium – structural analog of ipratr opium, approv ed for COPD, permits once daily dosing Delivered b y aerosol (metered dose inhaler/nebulizer) Slightly less effective than beta agonist     ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/

---

View Post: Foradil Aerolizer (Formoterol Fumarate Inhalation Powder) Drug ...
26 Jun 2008
Information on the pharmacokinetics of formoterol in plasma has been obtained in healthy subjects by oral inhalation of doses higher than the recommended range and in Chronic Obstructive Pulmonary Disease (COPD) patients after ..... This medication is not a substitute for inhaled or oral corticosteroids (e.g., beclomethasone, fluticasone, prednisone). This medication is usually used along with another controller-type asthma medication (such as inhaled corticosteroids). ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: Advances With Inhaled Corticosteroids
28 Dec 2006
Abstract; Daley-Yates P, Price A, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. ... New Drugs for Asthma, Allergy and COPD. Basel, Switzerland: Karger; 2001:91-93. Mackie AE, Ventresca GP, Fuller RW, Bye A. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. Br J Clin Pharmacol. 1996;41:539-542. ...
View Blog: Medscape Headlines - http://www.medscape.com/home

---

View Post: Successful Treatment of Previously Uncontrolled Adult Asthma with ...
20 Sep 2007 by Gawchik, S. M  
Asthma therapy at that time was beclomethasone dipropionate 2 puffs (84 µg/puff) twice daily in combination with salmeterol xinafoate pMDI 2 puffs (25 µg/puff) twice daily. Albuterol sulfate was administered for ..... Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998;35:273-9.[Medline]; Erickson SR, Horton A, Kirking DM. Assessing metered-dose inhaler ...
View Blog: Annals of Pharmacotherapy current issue - http://www.theannals.com/

---

View Post: Jornal Brasileiro de Pneumologia - Clinical phenotypes of severe ...
7 Nov 2008
In the treatment-resistant asthma group, a greater number of patients used oral corticosteroid therapy, daily inhaled corticosteroid therapy at a dosage >1200 µg of beclomethasone or equivalent, and the inhaled/oral corticosteroid .... In the present study, all patients diagnosed with COPD and current smokers were excluded. Some asthma patients can develop persistent obstruction,(11) and numerous factors can contribute to this finding such as adult onset disease, ...
View Blog: Jornal Brasileiro de Pneumologia - http://www.scielo.br/rss.php?pid=1806-371320080009&lang=en

---

View Post: Health and Quality of Life Outcomes
Full text
Effect of ... ...
View Blog: Acute exacerbations may cause deteriorations in the health status of subjects with chronic obstructive pulmonary disease (COPD). The present study prospectively evaluated the effects of such exacerbations on the health status and pulmonary .... an inhaled bronchodilator (anti-cholinergic agent and beta-2 agonist), and seventy-nine (50.6%) subjects received additional high dose ICS (beclomethasone dipropionate) at 1600 μg daily, and nine (5.8%) subjects also received oral

---